Our Lead Clinical Engineer Leads the Way
While STEM runs in her blood, building things that have an impact and help people are true to her heart. Meet Caitlin Schneider: Sonic Incytes’ Lead Clinical Engineer, who helped build Velacur, the first handheld 3D liver health assessment solution, in the lab with leading experts in medical ultrasound imaging Dr. Tim Salcudean and Dr. […]
Register for The Future of GI Webinar
Sonic Incytes is pleased to host the live educational webinar, Scope Forward: The Future of GI is Now in Your Hands. Join entrepreneur and healthcare futurist Praveen Suthrum and gastroenterologist Dr. Bradley Sklar to discover insights and practical advice for the industry to thrive, not just survive in the coming decade. Key points to be […]
Sonic Incytes Selected for MedTech Innovator Asia Pacific Accelerator
MedTech Innovator, the largest accelerator of medical device companies in the world, in partnership with Asia Pacific Medical Technology Association, announced on June 21 that Sonic Incytes Medical Corp. has been selected to participate in the organization’s Asia Pacific Accelerator program. Every year, MedTech Innovator selects the best and brightest medtech start-ups that are seeking […]
Are You at Risk? Fatty Liver Disease is a Silent, Deadly Epidemic
If there ever was a more urgent time to talk about fatty liver disease that time is now. While the headlines have been screaming about COVID-19, there is another epidemic that has been concealed in silence. That is, an epidemic of fatty liver disease. Approximately 1 in 4 persons worldwide has fatty liver disease, the […]
Sonic Incytes Selected for RESI Innovator’s Pitch Challenge
Sonic Incytes Medical Corp., the developer of VelacurTM, has been selected to participate in the Innovator’s Pitch Challenge at the upcoming Redefining Early Stage Investments (RESI) conference, held digitally June 8-10, 2021. The Innovator’s Pitch Challenge is an opportunity for early-stage companies to gain additional exposure to conference attendees and pitch directly to a panel […]
Live Webinar: Advances in NASH Drugs & The Role of NITs
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Advances in NASH Drugs & The Role of NITs. Join presenter Dr. Stephen Harrison, a Key Opinion Leader in NASH, to learn about the exciting progress of NASH drugs and non-invasive tests in addressing this emerging health crisis. Key points to be […]
Sonic Incytes Takes the Stage at LSI Emerging Medtech Summit
Sonic Incytes Medical Corp., the developers of VelacurTM, will take the stage at the LSI 2021 Emerging Medtech Summit to present its breakthrough solution for addressing fatty liver disease, an urgent, global health crisis exacerbated by the COVID-19 pandemic. Held May 11-13 in California, this premier event connects start-ups that have developed the most innovative […]
Are Your Patients at Risk? Fatty Liver Disease is a Silent, Deadly Epidemic
If there ever was a more urgent time to talk to your patients about fatty liver disease that time is now. While the headlines have been screaming about COVID-19, there is another epidemic that has been concealed in silence. That is, an epidemic of fatty liver disease. Approximately 1 in 4 persons worldwide has fatty […]
The Pandemic Diet: How COVID-19 Is Accelerating the Risk of Fatty Liver Disease
Did you turn to comfort food and cocktails during the pandemic? Well, you are not alone. According to the American Psychological Association’s survey of US adults in February 2021, the majority of adults (61 per cent) experienced undesired weight changes – weight gain or loss – since the pandemic started, with 42 per cent reporting they […]
Watch VelacurTM in Action at Liver Connect 2021
If you’re ready to transform your liver practice, we’re ready to show you how. Discover how fast, accurate and easy VelacurTM is to assess liver health at the inaugural Liver Connect conference, April 16-17, 2021, hosted by the Chronic Liver Disease Foundation. Visit our in-person booth for live demos of Velacur, the first handheld 3D […]
